Hexylresorcinol
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11254 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | obsolete vitamin D deficiency | KG + DL |
| 2 | sclerosing cholangitis | KG + DL |
| 3 | psoriasis | KG + DL |
| 4 | renal osteodystrophy | KG + DL |
| 5 | pityriasis lichenoides | KG + DL |
| 6 | impaired renal function disease | KG + DL |
| 7 | bone remodeling disease | KG + DL |
| 8 | obsolete hyperuricemia (disease) | KG + DL |
| 9 | severe nonproliferative diabetic retinopathy | KG + DL |
| 10 | cholecystolithiasis | KG + DL |
| 11 | acromesomelic dysplasia, Campailla Martinelli type | KG + DL |
| 12 | familial isolated hypoparathyroidism due to impaired PTH secretion | KG + DL |
| 13 | non-renal secondary hyperparathyroidism | KG + DL |
| 14 | parapsoriasis | KG + DL |
| 15 | craniofacial conodysplasia | KG + DL |
| 16 | hypophosphatemic rickets | KG + DL |
| 17 | Dahlberg-Borer-Newcomer syndrome | KG + DL |
| 18 | dry eye syndrome | KG + DL |
| 19 | renin-angiotensin-aldosterone system-blocker-induced angioedema | KG + DL |
| 20 | acute lichenoid pityriasis | KG + DL |
| 21 | seborrheic dermatitis | KG + DL |
| 22 | hyperparathyroidism, transient neonatal | KG + DL |
| 23 | conjunctivitis | KG + DL |
| 24 | hypoparathyroidism | KG + DL |
| 25 | osteomalacia (disease) | KG + DL |
| 26 | hereditary hypophosphatemic rickets | KG + DL |
| 27 | hypouricemia, renal | KG + DL |
| 28 | psoriasis 14, pustular | KG + DL |
| 29 | hypoxanthine guanine phosphoribosyltransferase partial deficiency | KG + DL |
| 30 | choledocholithiasis | KG + DL |
| 31 | diabetic retinopathy | KG + DL |
| 32 | acne (disease) | KG + DL |
| 33 | hypocalcemic rickets | KG + DL |
| 34 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 35 | drug-induced osteoporosis | KG + DL |
| 36 | anuria | KG + DL |
| 37 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 38 | renal artery obstruction | KG + DL |
| 39 | dyspepsia | KG + DL |
| 40 | pustulosis palmaris et plantaris | KG + DL |
| 41 | scleroderma (disease) | KG + DL |
| 42 | toxic labyrinthitis | KG + DL |
| 43 | diabetic nephropathy | KG + DL |
| 44 | guttate psoriasis | KG + DL |
| 45 | conductive hearing loss disorder | KG + DL |
| 46 | arteriosclerosis obliterans | KG + DL |
| 47 | pityriasis simplex | KG + DL |
| 48 | obsolete rare tumor of gallbladder and extrahepatic biliary tract | KG + DL |
| 49 | vitamin D-dependent rickets | KG + DL |
| 50 | parathyroid hyperplasia (disease) | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.